Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modifying disease in cystic fibrosis: current and future therapies on the horizon.

Current opinion in pulmonary medicine - 1 Nov 2013

Ong Thida, Ramsey Bonnie W

Abstract excerpt

PURPOSE OF REVIEW: Recent therapies directed at proximal targets within cystic fibrosis (CF) pathophysiology hold potential to modulate disease. This review highlights recent clinical trials and future therapies focused on these early steps of disease. RECENT FINDINGS: Recent approval of a CF transmembrane conductance regulator (CFTR) protein modulator, ivacaftor (Kalydeco), has ignited a wave of investigations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Biomarkers
Share to Cell Membrane

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Genetic Therapy

Share to Mannitol

Share to Quinolones

Source

Identifiers

PMID: 24048086
DOI: 10.1097/MCP.0b013e328365ab5f

Genes

CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modifying disease in cystic fibrosis: current and future therapies on the horizon.PMID 24048086Read ↗

Emerging drugs for cystic fibrosisSemantic proximity Read ↗

New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator.Semantic proximity Read ↗

Targeted therapy for cystic fibrosisSemantic proximity Read ↗

An update on new and emerging therapies for cystic fibrosis.Semantic proximity Read ↗

Advancing clinical development pathways for new CFTR modulators in cystic fibrosis.Semantic proximity Read ↗

Advances in the Cystic Fibrosis Drug Development PipelineSemantic proximity Read ↗

New and Emerging Treatments for Cystic Fibrosis.Semantic proximity Read ↗

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectivesSemantic proximity Read ↗

Cystic Fibrosis and Its Management Through Established and Emerging Therapies.Semantic proximity Read ↗

Cystic fibrosis: current therapeutic targets and future approaches.Semantic proximity Read ↗

Advances in the diagnosis and treatment of cystic fibrosis.Semantic proximity Read ↗

Precision Medicine Based on CFTR Genotype for People with Cystic FibrosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.